CLOs on the Move

Q2 Solutions

www.q2labsolutions.com

 
Q² Solutions, a Quintiles Quest joint venture Launched in 2015, Q² Solutions (pronounced Q-squared) is a leading global clinical trials laboratory services organization. We help biopharmaceutical, medical device and diagnostics customers improve human health through innovation that transforms science and data into actionable medical insights. Q² Solutions is a quality driven, responsive partner with strong global experience and deep scientific and medical expertise. The Q² Solutions joint venture was formed by Quintiles and Quest Diagnostics, combining the best of each parent organizations clinical trials laboratory services capabilities.
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion

Executives

Name Title Contact Details

Similar Companies

The Health Foundation of Greater Cincinnati

The Health Foundation of Greater Cincinnati is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Cincinnati, OH. To find more information about The Health Foundation of Greater Cincinnati, please visit www.healthfoundation.org

St. Andrew's Resources for Seniors

St. Andrew's Resources for Seniors is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. St. Andrew's Resources for Seniors is based in Saint Louis, MO. You can find more information on St. Andrew's Resources for Seniors at www.standrews1.com

Senesco Technologies, Inc.

Senesco Technologies, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in New Brunswick, NJ. To find more information about Senesco Technologies, Inc., please visit www.senesco.com

Hanna Instruments

Hanna Instruments is a Ann Arbor, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Unchained Labs

Unchained Labs is committed to building the first cool biologics tools company. One with products that`ll make a real difference in the research scientists do every day. One that UNleashes tools that help them characterize their biologics better. Founded in January 2015, we have raised $31M of venture capital and have purchased two product lines. First, we let loose the UNit, the world`s first and only multiplex protein stability platform. Next we landed another big win with ICD, the world`s first quantitative stability predictor. With these two products, we have established ourselves as the experts in protein stability